White & Case LLP
Jack Pace is a core member of White & Case's leading global antitrust litigation practice, which is ranked by Chambers USA in Band 1 for cartel matters and is the only practice at any firm to win Competition Group of the Year from Law360 for six years in a row.
Jack is also Head of the Competition Section for the Firm's Americas Region.
Drawing upon energy, creativity, and persuasive abilities well known to the Firm's clients, Jack has achieved major victories in many complex litigation matters, including jury verdicts (Fair Isaac v. Experian), appellate victories (Doryx "product hopping" litigation, GM seeds antitrust litigation), dismissals of antitrust claims on the pleadings and at summary judgment (numerous "reverse payment" and "product hopping" cases, White v. JP Morgan Chase, VantageScore antitrust litigation), and groundbreaking defeats of class certification (Blades v. Monsanto).
Jack represents several leading global pharmaceutical companies (including Allergan, Pfizer, and Boehringer Ingelheim) in class action litigation matters at the cutting edge of antitrust and intellectual property.
He has been recognized as a leading antitrust lawyer by several publications. Jack is a two-time "MVP" by Law360, winning the award in the Life Sciences category 2015 and in the Competition category in 2011. Jack also was named a "Rising Star under age 40" among US competition lawyers by Law360 in 2013 and a "Rising Star" among all New York lawyers by the New York Law Journal in 2013.
Jack works with clients across a broad spectrum of industries, including pharmaceuticals, financial services, agriculture, energy, and insurance.